Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Kay‐Uwe Wagner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-5081-0226; OpenAlex author ID A5054645034; NIH RePORTER profile ID 6798938. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 4)
Trials
0
Grants
2
Labs led
2
Collaborators
41
Papers, trials and grants by year

2012: 1 paper, 1 grant · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers, 1 grant · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 10

  1. RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth. Co-author DOI 10.1016/j.canlet.2024.217275↗
  2. The Janus kinase 1 is critical for pancreatic cancer initiation and progression. Last author DOI 10.1016/j.celrep.2024.114202↗
  3. Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis Co-author DOI 10.1101/2023.12.18.572102↗
  4. Models of pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s10555-021-09989-9↗
  5. Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside. Co-author DOI 10.3390/cancers13112777↗
  6. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Co-author DOI 10.1038/ncomms7744↗
  7. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3308↗
  8. Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapies. Last author DOI 10.1158/0008-5472.can-13-3437↗
  9. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Last author DOI 10.1158/0008-5472.can-12-2067↗
  10. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Co-author DOI 10.1186/1756-8722-5-68↗

Grants 2

  1. JAK1 Signaling in Pancreatic Cancer Initiation and Progression R01CA202917↗
  2. Temporally controlled oncogene expression in a novel pancreatic cancer model R21CA155175↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Md. Hafiz Uddin · 3 shared papers, 2021–2024 · strength 0.48
  2. Asfar Sohail Azmi · 3 shared papers, 2021–2024 · strength 0.48
  3. Hridaya Shrestha · 2 shared papers, 2021–2024 · strength 0.41
  4. Rayane Dennaoui · 2 shared papers, 2021–2024 · strength 0.41
  5. Sahar F. Bannoura · 2 shared papers, 2023–2024 · strength 0.33
  6. Boris Pasche · 2 shared papers, 2023–2024 · strength 0.33
  7. Husain Yar Khan · 2 shared papers, 2023–2024 · strength 0.33
  8. Eliza Wright Beal · 2 shared papers, 2023–2024 · strength 0.33
  9. Amro Aboukameel · 2 shared papers, 2023–2024 · strength 0.33
  10. Ramzi M. Mohammad · 2 shared papers, 2021–2024 · strength 0.32
  11. Philip A. Philip · 2 shared papers, 2021–2024 · strength 0.32
  12. Nirakar Rajbhandari · 3 shared papers, 2013–2024 · strength 0.28
  13. Dieter Saur · 1 shared paper, 2024 · strength 0.18
  14. Muhammad Wasif Saif · 1 shared paper, 2024 · strength 0.17
  15. Bassel F. El‐Rayes · 1 shared paper, 2024 · strength 0.17
  16. Wan-Chi Lin · 3 shared papers, 2013–2015 · strength 0.14
  17. Surinder K. Batra · 3 shared papers, 2012–2015 · strength 0.11
  18. María P. Torres · 2 shared papers, 2012–2015 · strength 0.08
  19. Satyanarayana Rachagani · 2 shared papers, 2012–2015 · strength 0.08
  20. Agnieszka Katarzyna Witkiewicz · 2 shared papers, 2013–2015 · strength 0.07
  21. Srustidhar Das · 1 shared paper, 2015 · strength 0.05
  22. Lynette M. Smith · 1 shared paper, 2015 · strength 0.05
  23. Imayavaramban Lakshmanan · 1 shared paper, 2015 · strength 0.05
  24. GuemHee Baek · 1 shared paper, 2015 · strength 0.04
  25. Adam Charles Yopp · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.